Literature DB >> 10916518

Impact of a camp experience on phenylalanine levels, knowledge, attitudes, and health beliefs relevant to nutrition management of phenylketonuria in adolescent girls.

R H Singh1, J A Kable, N V Guerrero, K M Sullivan, L J Elsas.   

Abstract

OBJECTIVE: To evaluate the effectiveness of an education intervention in a summer camp setting on knowledge, attitudes, and health beliefs regarding metabolic control of phenylketonuria and dietary compliance.
DESIGN: An observational study of a weeklong metabolic camp for adolescent girls with phenylketonuria (PKU) who were followed up over the course of 1 year. Observations also were made in 3 subsequent years of camp. INTERVENTION: The camp experience consisted of diet and disease education, sessions on reproductive development, and recreation. Group discussions on attitudes and perceptions about PKU related to dietary compliance were held with nutritionists and a pediatric psychologist. OUTCOME MEASURES: Biochemical and psychological data were collected on the first and last days of the camp to assess short-term effects of the intervention, then at quarterly intervals during the year to determine the long-term impact of the camp. Precamp and Postcamp plasma amino acid data for the subsequent 3 years were also collected. SUBJECTS/
SETTING: Analyses were based on 13 adolescent girls with PKU in the first year of a camp at Emory University in Atlanta, Ga, and compared with data from 11 additional campers enrolled the second year, 8 in the third year, and 7 in the fourth year. Mean age +/- standard deviation of first-year campers was 13 +/- 2 years, mean IQ +/- standard deviation was 98 +/- 16, and 9 of 13 girls had menstruated. STATISTICAL ANALYSES PERFORMED: Short-term effects of the intervention were computed by comparing mean levels of response from the baseline period to those from the last day of camp using t tests for dependent samples. Repeated-measures analysis of variance was used to assess the long-term effects of the camp experience over the course of a year at regular quarterly intervals.
RESULTS: Short-term effects of the education intervention were significant reductions in dietary phenylalanine intake, plasma phenylalanine levels, and perceived isolation. However, these effects progressively returned to baseline levels over the course of a year. The significant short- and long-term effects of increased knowledge of diet and disease persisted throughout the study period. APPLICATIONS/
CONCLUSIONS: Short-term effects of the education intervention resulted in improved metabolic control associated with improved attitudes, increased knowledge of diet and disease, increased perceived support, and decreased barriers to dietary compliance in a camp setting.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10916518     DOI: 10.1016/s0002-8223(00)00232-7

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


  13 in total

1.  Influence of knowledge of the disease on metabolic control in phenylketonuria.

Authors:  Jolita Bekhof; Francjan J van Spronsen; Matty R Crone; Margreet van Rijn; Carin G M Oudshoorn; Paul H Verkerk
Journal:  Eur J Pediatr       Date:  2003-04-08       Impact factor: 3.183

2.  Nutritional Management of Phenylketonuria.

Authors:  Erin L Macleod; Denise M Ney
Journal:  Ann Nestle Eng       Date:  2010-06

3.  Demographic and Psychosocial Influences on Treatment Adherence for Children and Adolescents with PKU: A Systematic Review.

Authors:  Emma Medford; Dougal Julian Hare; Anja Wittkowski
Journal:  JIMD Rep       Date:  2017-08-25

4.  Docosahexaenoic acid status in females of reproductive age with maple syrup urine disease.

Authors:  Laura M Mazer; Sarah H L Yi; Rani H Singh
Journal:  J Inherit Metab Dis       Date:  2010-03-09       Impact factor: 4.982

5.  Behavioral predictors of medication adherence trajectories among youth with newly diagnosed epilepsy.

Authors:  Kristin Loiselle; Joseph R Rausch; Avani C Modi
Journal:  Epilepsy Behav       Date:  2015-07-25       Impact factor: 2.937

Review 6.  Drug compliance in adolescents: assessing and managing modifiable risk factors.

Authors:  Betty Staples; Terrill Bravender
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 7.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

8.  Phenylketonuria patients' and their parents' acceptance of the disease: multi-centre study.

Authors:  Ewa Witalis; Bożena Mikoluc; Radoslaw Motkowski; Justyna Szyszko; Agnieszka Chrobot; Bozena Didycz; Agata Lange; Renata Mozrzymas; Andrzej Milanowski; Maria Nowacka; Mariola Piotrowska-Depta; Hanna Romanowska; Ewa Starostecka; Jolanta Wierzba; Magdalena Skorniewska; Barbara Iwona Wojcicka-Bartlomiejczyk; Maria Gizewska
Journal:  Qual Life Res       Date:  2016-05-31       Impact factor: 4.147

9.  Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride.

Authors:  Teresa D Douglas; Usha Ramakrishnan; Julie A Kable; Rani H Singh
Journal:  Health Qual Life Outcomes       Date:  2013-12-30       Impact factor: 3.186

10.  Requirements for a minimum standard of care for phenylketonuria: the patients' perspective.

Authors:  Tobias S Hagedorn; Paul van Berkel; Gregor Hammerschmidt; Markéta Lhotáková; Rosalia Pasqual Saludes
Journal:  Orphanet J Rare Dis       Date:  2013-12-17       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.